SCHEMBL133636

SCHEMBL133636

CCCCC(=O)OCc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.59
L3MBTL1 Q9Y468 3/20 0.59
MAPK1 P28482 2/20 0.59
TDP1 Q9NUW8 4/20 0.58
CYP3A4 P08684 1/20 0.58
TSHR P16473 1/20 0.58
KMT2A Q03164 4/20 0.53
MEN1 O00255 3/20 0.53
HPGD P15428 1/20 0.53
LMNA P02545 1/20 0.52
CETP P11597 3/20 0.51
KDM4E B2RXH2 1/20 0.51
RECQL P46063 1/20 0.51
SLC6A2 P23975 1/20 0.50
SLC6A3 Q01959 1/20 0.50
ALOX5 P09917 1/20 0.48
POLB P06746 1/20 0.48
HTT P42858 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL27569528 0.98 ALDH1A1 (0.58) ALDH1A1L3MBTL1MAPK1TDP1CYP3A4
Hydrochloric Acid SCHEMBL28136732 0.98 ALDH1A1 (0.58) ALDH1A1L3MBTL1MAPK1TDP1CYP3A4
Valeric Acid SCHEMBL28813456 0.95 HTT (0.55) ALDH1A1L3MBTL1MAPK1TDP1CYP3A4
SCHEMBL28530002 0.95 ALDH1A1 (0.58) ALDH1A1L3MBTL1MAPK1TDP1CYP3A4
SCHEMBL135437 0.95 ALDH1A1 (0.58) ALDH1A1L3MBTL1MAPK1TDP1CYP3A4
SCHEMBL20456996 0.94 ALDH1A1 (0.53) ALDH1A1L3MBTL1MAPK1TDP1CYP3A4
SCHEMBL296362 0.93 ALDH1A1 (0.57) ALDH1A1L3MBTL1MAPK1TDP1CYP3A4
SCHEMBL9802928 0.93 ALDH1A1 (0.57) ALDH1A1L3MBTL1MAPK1TDP1CYP3A4
SCHEMBL2457043 0.93 ALDH1A1 (0.57) ALDH1A1L3MBTL1MAPK1TDP1CYP3A4
SCHEMBL6832768 0.93 ALDH1A1 (0.57) ALDH1A1L3MBTL1MAPK1TDP1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 619 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119823825-A Myrtle essential oil and application of compound essential oil based on myrtle essential oil in pest control 广东海洋大学 2025-04-15 CN claimed
CN-118833832-B Oil-ice semi-solid phase coprecipitation process for synthesizing Prussian blue type positive electrode material 哈尔滨工业大学 2025-02-07 CN claimed
US-12139627-B2 Perovskite ink formulations EXCYTON LIMITED (GB) 2024-11-12 US claimed
CN-118833832-A Oil-ice semi-solid phase coprecipitation process for synthesizing Prussian blue type positive electrode material 哈尔滨工业大学 2024-10-25 CN claimed
CN-118047704-A 1- (Carbonyl) -3- ((methylthio) methyl) cyclobutane-1-benzyl formate derivative and preparation method thereof 浙大城市学院 2024-05-17 CN claimed
EP-4356894-A1 SUSTAINABLE PRODUCT WITH MALODORS Beiersdorf AG (DE) 2024-04-24 EP claimed
CN-113607844-B Application of compound as chromatographic protective agent, protective liquid and method for analyzing flavor components in cigarette smoke 中国烟草总公司郑州烟草研究院 2023-10-20 CN claimed
US-20220185759-A1 PROCESSES FOR PRODUCING CARBOXYLIC ACIDS EASTMAN CHEMICAL COMPANY (US) 2022-06-16 US claimed
EP-3947337-A1 PROCESSES FOR PRODUCING CARBOXYLIC ACIDS EASTMAN CHEMICAL COMPANY (US) 2022-02-09 EP claimed
CN-113607844-A Application of compound as chromatographic analysis protective agent, protective solution and method for analyzing aroma components in cigarette smoke 中国烟草总公司郑州烟草研究院 2021-11-05 CN claimed
CN-101795701-A Inhibitors of acetyl COA carboxylase for the treatment of neuronal hypometabolism ACCERA INC 2010-08-04 CN claimed
CN-100480242-C CDK-inhibiting pyrimidine compounds, method for the production thereof and use thereof as medicaments SCHERING AG (DE) 2009-04-22 CN claimed
EP-1958956-A2 Peptidomimetic protease inhibitors Vertex Pharmaceuticals Incorporated (US) 2008-08-20 EP claimed
EP-1490469-A2 METHODS AND COMPOSITIONS FOR REMOVING RESIDUES AND SUBSTANCES FROM SUBSTRATES USING ENVIRONMENTALLY FRIENDLY SOLVENTS North Carolina State University (US) 2004-12-29 EP claimed
JP-2004517047-A 2004-06-10 JP claimed
CN-1479721-A Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol therapy and related applications ͨ��ҽ�ƹ�˾ 2004-03-03 CN claimed
US-20030213747-A1 Methods and compositions for removing residues and substances from substrates using environmentally friendly solvents NORTH CAROLINA STATE UNIVERSITY 2003-11-20 US claimed
WO-2003072215-A2 METHODS AND COMPOSITIONS FOR REMOVING RESIDUES AND SUBSTANCES FROM SUBSTRATES USING ENVIRONMENTALLY FRIENDLY SOLVENTS NORTH CAROLINA STATE UNIVERSITY (US) 2003-09-04 WO claimed
EP-1320540-A2 PEPTIDOMIMETIC PROTEASE INHIBITORS ELI LILLY AND COMPANY (US) 2003-06-25 EP claimed
WO-2002018369-A2 PEPTIDOMIMETIC PROTEASE INHIBITORS ELI LILLY AND COMPANY (US) 2002-03-07 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220185759-A1 PROCESSES FOR PRODUCING CARBOXYLIC ACIDS HAO2, HPD, DDO ALDH1A1 209/4885L3MBTL1 4826/4885MAPK1 2112/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.